BIIB091
BIIB091 is a potent, selective, orally active and reversible BTK inhibitor, with an IC50 of [1].
Product Specifications
CAS Number
2247614-80-6
UNSPSC
12352005
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/biib091.html
Purity
99.85
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(C1=CN(C(C)(C)C)N=N1)N[C@H]2C3=CC=C(C4=CC=NC(NC5=CN(C)N=C5)=N4)C=C3CN(C6COC6)CC2
Molecular Formula
C28H34N10O2
Molecular Weight
542.64
References & Citations
[1]Hopkins BT, et al. Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis. J Med Chem. 2021 Nov 4.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A00784-2-Dylight594 100 µg
Anti-MADH7/SMAD7 Antibody Picoband®, Dylight594 Conjugate
Sign In for Pricing
View Details E45M10277V-2 50 µL
KIST (UHMK1) Mouse Monoclonal Antibody [Clone 2D3]
Sign In for Pricing
View Details 
BNUB3810-100 1x 100 µL
SOX2 (Embryonic Stem Cell Marker) (rSOX2/1792), 0.2mg/mL
Sign In for Pricing
View Details